Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages

Oncology Letters

Volumn 1, Issue 1, 2010, Pages 167-176

  Dogan, Soner ^a   Rogozina, Olga P ^a   Lokshin, Anna E ^b   Grande, Joseph P ^c   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Adiponectin; Adiponectin leptin ratio; Breast cancer; Calorie restriction; Energy restriction; Leptin; Mammary tumor; Mouse

Indexed keywords

ADIPONECTIN; LEPTIN; TRANSFORMING GROWTH FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; BREAST TUMOR; CALORIC RESTRICTION; CANCER CELL CULTURE; CANCER INCIDENCE; CHRONIC CALORIE RESTRICTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; HUMAN; HUMAN CELL; INTERMITTENT CALORIE RESTRICTION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; OUTCOME ASSESSMENT; TUMOR GROWTH;

EID: 77949557082     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000031     Document Type: Article

References (62)

1. Dirx MJ, Zeegers MP, Dagnelie PC, Van den Bogaard T and Van den Brandt PA: Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106: 766-770, 2003.
2. Pariza MW: Fat, calories, and mammary carcinogenesis: net energy effects. Am J Clin Nutr 45: 261-263, 1987.
3. Tucker MJ: The effect of long-term food restriction on tumours in rodents. Int J Cancer 23: 803-807, 1979.
4. Gillette CA, Zhu Z, Westerlind KC, Melby CL, Wolfe P and Thompson HJ: Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis 18: 1183-1188, 1997.
5. Cleary MP, Hu X, Grossmann ME, et al: Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med 232: 70-80, 2007.
6. Cleary MP, Jacobson MK, Phillips FC, Getzin SC, Grande JP and Maihle NJ: Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. Cancer Epidemiol Biomarkers Prev 11: 836-843, 2002.
7. Thompson HJ, McGinley JN, Spoelstra NS, Jiang W, Zhu Z and Wolfe P: Effect of dietary energy restriction on vascular density during mammary carcinogenesis. Cancer Res 64: 5643-5650, 2004.
8. Zhu Z, Jiang W and Thompson HJ: An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction. Mol Carcinog 35: 51-56, 2002.
9. Engelman RW, Day NK, Chen RF, et al: Calorie consumption level influences development of C3H/Ou breast adenocarcinoma with indifference to calorie source. Proc Soc Exp Biol Med 193: 23-30, 1990.
10. Carlson JA and Hoelzel F: Apparent prolongation of the life span of rats by intermittent fasting: one figure. J Nutr 31: 363-375, 1946.
11. Pape-Ansorge KA, Grande JP, Christensen TA, Maihle NJ and Cleary MP: Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice. Nutr Cancer 44: 162-168, 2002.
12. Hankinson SE and Schernhammer ES: Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Dis 17: 27-40, 2003.
13. Hartman J, Lindberg K, Morani A, Inzunza J, Strom A and Gustafsson JA: Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 66: 11207-11213, 2006.
14. Kaaks R: Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262: 247-260; discussion 260-268, 2004.
15. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, et al: Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150: 161-171, 2004.
16. Chen DC, Chung YF, Yeh YT, et al: Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer letters 237: 109-114, 2006.
17. Nakayama S, Miyoshi Y, Ishihara H and Noguchi S: Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat 112: 405-410, 2008.
18. Hu X, Juneja SC, Maihle NJ and Cleary MP: Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704-1711, 2002.
19. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A and Cleary MP: Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98: 370-379, 2008.
20. Ray A, Nkhata KJ and Cleary MP: Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30: 1499-1509, 2007.
21. Vona-Davis L and Rose DP: Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14: 189-206, 2007.
22. Korner A, Pazaitou-Panayiotou K, Kelesidis T, et al: Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92: 1041-1048, 2007.
23. Miyoshi Y, Funahashi T, Kihara S, et al: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9: 5699-5704, 2003.
24. Tworoger SS, Eliassen AH, Kelesidis T, et al: Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92: 1510-1516, 2007.
25. Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP and Maihle NJ: Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med 229: 182-193, 2004.
26. Cleary MP, Phillips FC, Getzin SC, et al: Genetically obese MMTV-TG F-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 77: 205-215, 2003.
27. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y and Pecquery R: Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345: 271-279, 2006.
28. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R and Giudicelli Y: Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293: 622-628, 2002.
29. Grossmann EM, Ray A, Dogan S, Mizuno KN and Cleary MP: Balance of adiponectin and leptin in relationship to breast cancer cell growth. Cell Research (In press).
30. Mistry T, Digby JE, Desai KM and Randeva HS: Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU Int 101: 1317-1322, 2008.
31. Fenton JI, Birmingham JM, Hursting SD and Hord NG: Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer 122: 2437-2445, 2008.
32. Matsui Y, Halter SA, Holt JT, Hogan BL and Coffey RJ: Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 61: 1147-1155, 1990.
33. Lundy J, Schuss A, Stanick D, McCormack ES, Kramer S and Sorvillo JM: Expression of neu protein, epidermal growth factor receptor and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters. Am J Pathol 138: 1527-1534, 1991.
34. Murray PA, Barrett-Lee P, Travers M, Luqmani Y, Powles T and Coombes RC: The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 67: 1408-1412, 1993.
35. Rajkumar T and Gullick WJ: The type I growth factor receptors in human breast cancer. Breast Cancer Res Treat 29: 3-9, 1994.
36. Panico L, D'Antonio A, Salvatore G, et al: Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CR IPTOTO in human normal and malignant breast tissues. Int J Cancer 65: 51-56, 1996.
37. Reeves PG, Nielsen FH and Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993.
38. Bonorden MJL, Rogozina OP, Kluczny CM, Grossmann ME, Grambsch PL, Grande JP, Perkins SN, Lokshin A and Cleary MP: Intermittent calorie restriction delays prostate tumor detection and increases survival time in TR AMP mice. Nutr Cancer 61: 265-275, 2009.
39. Bonorden MJL, Rogozina OP, Kluczny CM, Grossmann ME, Grande JP, Loshkin A and Cleary MP: Cross-sectional analysis of intermittent versus chronic caloric restriction in the TR AMP mouse. Prostate 69: 317-326, 2009.
40. Rogozina OP, Bonorden MJL, Grande JP and Cleary MP: Serum insulin like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted and intermittent calorie-restricted MMTV-TG F-α mice. Cancer Prev Res 2: 712-719, 2009.
41. Silha JV, Weiler HA and Murphy LJ: Plasma adipokines and body composition in response to modest dietary manipulations in the mouse. Obesity 14: 1320-1329, 2006.
42. Varady KA, Roohk DJ, Loe YC, McEvoy-Hein BK and Hellerstein MK: Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. J Lipid Res 48: 2212-2219, 2007.
43. Bluher M, Fasshauer M, Kralisch S, Schon MR, Krohn K and Paschke R: Regulation of adiponectin receptor R1 and R2 gene expression in adipocytes of C57BL/6 mice. Biochem Biophys Res Commun 329: 1127-1132, 2005.
44. Barnea M, Shamay A, Stark AH and Madar Z: A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity 14: 2145-2153, 2006.
45. Wang Z, Masternak MM, Al-Regaiey KA and Bartke A: Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148: 2845-2853, 2007.
46. Ryan AS, Nicklas BJ, Berman DM and Elahi D: Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 27: 1066-1071, 2003.
47. Gavrila A, Chan JL, Yiannakouris N, et al: Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88: 4823-4831, 2003.
48. Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
49. Hulver MW, Zheng D, Tanner CJ, et al: Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283: E861-E865, 2002.
50. Yang WS, Lee WJ, Funahashi T, et al: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819, 2001.
51. Weiss EP, Racette SB, Villareal DT, et al: Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr 84: 1033-1042, 2006.
52. Zhang Y, Matheny M, Zolotukhin S, Tumer N and Scarpace PJ: Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 1584: 115-122, 2002.
53. Grossmann ME, Ray A, Dogan S, Mizuno NK and Cleary MP: Balance of adiponectin and leptin in relationship to breast cancer cell growth. Cell Res 18: 1154-1156, 2008.
54. Nkhata KJ, Ray A, Dogan S, Grande JP and Cleary MP: Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements. Breast Cancer Res Treat 114: 71-83, 2009.
55. Matsubara M, Maruoka S and Katayose S: Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147: 173-180, 2002.
56. Cnop M, Havel PJ, Utzschneider KM, et al: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459-469, 2003.
57. Vendrell J, Broch M, Vilarrasa N, et al: Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12: 962-971, 2004.
58. Anderlova K, Kremen J, Dolezalova R, et al: The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol Res 55: 277-283, 2006.
59. Cleary MP, Grande JP, Juneja SC and Maihle NJ: Diet-induced obesity and mammary tumor development in MMTV-neu female mice. Nutr Cancer 50: 174-180, 2004.
60. Ray A, Nkhata KJ, Grande JP and Cleary MP: Diet-induced obesity and mammary tumor development in relation to estrogen receptor status. Cancer Lett 253: 291-300, 2007.
61. Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP and Cleary MP: Effects of high fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TG F-alpha mice. Breast Cancer Res 9: R91, 2007.
62. Ostlund RE Jr, Yang JW, Klein S and Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates. J Clin Endocrinol Metab 81: 3909-3913, 1996.